Extreme volatility in the NZ dollar is affecting its business, Fisher & Paykel Healthcare says, and its response is to ramp up manufacturing in Mexico.
The company forecast full-year operating revenue in the range of $515 million to $530 million and net profit after tax in the range of $60 million to $65 million.
"We had planned to place about half of our high-volume consumables capacity in Mexico within five years. We intend to accelerate that process to achieve the expected $20 million of annual savings sooner," chief executive Michael Daniell said.
